222 companies

Commvault Systems

Market Cap: US$7.4b

Provides a cyber resilience platform for protecting and recovering data and cloud-native applications in the Americas and internationally.

CVLT

US$165.97

7D

-2.9%

1Y

35.8%

Quoin Pharmaceuticals

Market Cap: US$4.9m

A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.

QNRX

US$8.56

7D

-2.1%

1Y

-60.6%

Unicycive Therapeutics

Market Cap: US$58.3m

A clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States.

UNCY

US$4.85

7D

4.3%

1Y

10.2%

Vertex Pharmaceuticals

Market Cap: US$122.5b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

VRTX

US$472.27

7D

1.9%

1Y

-4.1%

CleanSpark

Market Cap: US$3.5b

Operates as a bitcoin mining company in the Americas.

CLSK

US$12.34

7D

-4.9%

1Y

-23.7%

BeOne Medicines

Market Cap: US$35.0b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

ONC

US$296.46

7D

2.1%

1Y

81.6%

Anavex Life Sciences

Market Cap: US$1.1b

Operates as a biopharmaceutical company.

AVXL

US$12.74

7D

15.2%

1Y

86.3%

Krystal Biotech

Market Cap: US$4.4b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

KRYS

US$150.00

7D

-0.1%

1Y

-28.8%

Semrush Holdings

Market Cap: US$1.5b

Develops an online visibility management software-as-a-service platform in the United States, the United Kingdom, and internationally.

SEMR

US$9.58

7D

5.7%

1Y

-32.3%

Glimpse Group

Market Cap: US$33.5m

An immersive technology company provides enterprise focused virtual reality (VR), augmented reality (AR), and spatial computing software and services in the United States.

VRAR

US$1.60

7D

8.8%

1Y

73.8%

Fennec Pharmaceuticals

Market Cap: US$241.1m

Operates as a commercial stage biopharmaceutical company in the United States.

FENC

US$8.72

7D

-0.3%

1Y

31.9%

Amicus Therapeutics

Market Cap: US$1.9b

A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.

FOLD

US$6.28

7D

-0.2%

1Y

-38.8%

Evaxion

Market Cap: US$16.9m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

EVAX

US$2.71

7D

2.3%

1Y

-81.4%

MNTN

Market Cap: US$2.2b

A performance TV software company, provides performance advertising services in the United States.

MNTN

US$29.18

7D

4.8%

1Y

n/a

Protalix BioTherapeutics

Market Cap: US$127.4m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

PLX

US$1.55

7D

3.3%

1Y

34.8%

BitFuFu

Market Cap: US$665.5m

Provides digital asset mining solutions in North America, Asia, Europe, and internationally.

FUFU

US$4.01

7D

3.4%

1Y

-20.0%

Day One Biopharmaceuticals

Market Cap: US$703.5m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

DAWN

US$7.21

7D

10.9%

1Y

-54.6%

Creative Medical Technology Holdings

Market Cap: US$7.1m

A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.

CELZ

US$2.72

7D

3.8%

1Y

-23.5%

Clene

Market Cap: US$33.6m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

CLNN

US$3.66

7D

-6.2%

1Y

-17.9%

Trade Desk

Market Cap: US$41.6b

Operates as a technology company in the United States and internationally.

TTD

US$85.00

7D

4.4%

1Y

-6.5%

ImmunityBio

Market Cap: US$2.6b

A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.

IBRX

US$3.01

7D

6.4%

1Y

-45.2%

Take-Two Interactive Software

Market Cap: US$41.8b

Develops, publishes, and markets interactive entertainment solutions for consumers worldwide.

TTWO

US$225.75

7D

-3.5%

1Y

50.2%

ServiceNow

Market Cap: US$198.4b

Provides cloud-based solution for digital workflows in the North America, Europe, the Middle East and Africa, Asia Pacific, and internationally.

NOW

US$996.18

7D

3.9%

1Y

20.2%

Bit Digital

Market Cap: US$1.1b

Engages in the bitcoin mining business.

BTBT

US$3.23

7D

-19.5%

1Y

-8.5%

IREN

Market Cap: US$4.6b

Operates in the integrated data center business.

IREN

US$18.14

7D

0.5%

1Y

92.4%

Corning

Market Cap: US$47.8b

Operates in optical communications, display technologies, environmental technologies, specialty materials, and life sciences businesses.

GLW

US$55.72

7D

2.8%

1Y

30.2%

Sierra Oncology

Market Cap: US$1.3b

Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.

SRRA

US$54.99

7D

0.06%

1Y

179.4%

Protagonist Therapeutics

Market Cap: US$3.4b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

PTGX

US$53.74

7D

-4.8%

1Y

29.3%

Bitdeer Technologies Group

Market Cap: US$2.9b

Operates as a technology company for blockchain and high-performance computing (HPC) in Singapore, the United States, Bhutan, and Norway.

BTDR

US$15.16

7D

10.3%

1Y

57.1%

Apellis Pharmaceuticals

Market Cap: US$2.5b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

APLS

US$20.09

7D

0.2%

1Y

-48.3%

Zai Lab

Market Cap: US$4.1b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

ZLAB

US$37.77

7D

4.9%

1Y

100.2%

AmpliTech Group

Market Cap: US$55.3m

Designs, engineers, and assembles micro-wave component-based amplifiers.

AMPG

US$3.16

7D

7.8%

1Y

168.9%

Geron

Market Cap: US$847.1m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

GERN

US$1.28

7D

-0.8%

1Y

-70.2%

Aprea Therapeutics

Market Cap: US$10.7m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

APRE

US$1.93

7D

15.6%

1Y

-50.0%

Applied Optoelectronics

Market Cap: US$1.5b

Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.

AAOI

US$25.84

7D

-12.2%

1Y

200.1%

Arcturus Therapeutics Holdings

Market Cap: US$419.0m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

ARCT

US$14.95

7D

10.4%

1Y

-34.9%

Page 3 of 7